Menu

Image of the Day: Life and Death

When hair follicle stem cells lose their protein-based death cue, they take on a new role helping to repair wounds in skin.

Mar 22, 2019
Carolyn Wilke

ABOVE: Proliferating cells (red) and hair follicle stem cells (green) from a mouse’s tail
YARON FUCHS & SAMARA BROWN. ADOPTED FROM YOSEFZON ET AL., 2018 MOLECULAR CELL

Yaron Fuchs of the Technion Israel Institute of Technology investigates what leads stem cells down the path to apoptosis, one type of programmed cell death. To get at the roots of cellular suicide in these self-renewing cells, Fuchs is examining the phenomenon’s associated proteins in hair follicles, a model cell population, in mice. 

His lab has found that in mice missing a gene for a particular apoptosis-promoting protein, hair follicle stem cells proliferate and take on a new role helping to regenerate skin and repair skin wounds. The work suggests that unleashing proteins that bring on or hinder apoptosis in stem cells could lead to new treatments for wounds, according to an essay by Fuchs published on March 8 in Science.

Fuchs is the winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy, the American Association for the Advancement of Science announced March 7.

Y. Fuchs, “The therapeutic promise of apoptosis,” Science, doi:10.1126/science.aaw3607, 2019.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.